Revvity | Actif À Court Terme



Current Assets Changement Date
Adcock Ingram Holdings ZAR 4.89B 194.86M 2024-06
Agilent USD 4.11B 148M 2025-01
Align Technology USD 2.49B 104.95M 2024-12
Bio Techne USD 634.64M 13.93M 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
Bruker USD 2.06B 133.1M 2024-12
Celltrion KRW 5.37T 121.47B 2024-09
Charles River Laboratories USD 1.4B 91.65M 2024-12
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Danaher USD 9.5B 563M 2024-12
Dentsply International USD 1.75B 175M 2024-12
Dianthus Therapeutics USD 280.9M 6.58M 2024-12
Ecofibre AUD 37.37M 2.03M 2024-06
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Exact Sciences USD 1.57B 38.31M 2024-12
Hologic USD 3.49B 329.7M 2024-12
Illumina USD 2.75B 373M 2024-12
Intuitive Surgical USD 11.54B 4.33B 2024-12
IQVIA Holdings USD 5.83B 197M 2024-12
Kangmei Pharma CNY 7.01B 15.81M 2024-09
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 489.61M 51.17M 2024-12
Laboratory Of America USD 4.81B 103.4M 2024-12
Malin Corporation EUR 35.9M 100K 2024-06
Medical Developments International AUD 26.14M 4.89M 2024-06
Mettler Toledo International USD 1.19B 4.33M 2024-12
Myriad Genetics USD 298M 4.8M 2024-12
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 231.49M 30.73M 2024-12
Patterson Companies USD 1.84B 4.38M 2025-01
Pharma Mar EUR 250.25M 12.23M 2024-12
Qiagen NV USD 1.96B 494.22M 2024-12
Quest Diagnostics USD 2.39B 231M 2024-12
Quidel USD 1.22B 193.7M 2024-12
Repligen USD 1.13B 27.35M 2024-09
Revvity USD 2.35B 98.8M 2024-12
Sartorius EUR 1.97B 114.6M 2024-09
Sino Biopharmaceutical CNY 24.69B 536.67M 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Tilray USD 707.34M 18.54M 2024-11
Waters USD 1.67B 21.39M 2024-12
Zz Pientze Pharmaceu 15.84B 718.65M 2024-09



Revvity Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.